WebEase: Epilepsy, Awareness, Support, and Education

Emory Prevention Research Center

A woman working on a laptop

A Prevention Research Center Tool Showing Evidence of Effectiveness


WebEase is a free, web-based program to help adults with epilepsy improve management of their epilepsy. Each user can personalize a WebEase account (accessible through a computer or tablet) by answering a variety of questions about their symptoms and self-management strategies. The program offers three learning modules:

  • Medication management.
  • Stress reduction.
  • Sleep management.

These modules allow users to read information and answer questions, get personalized feedback based on their answers, and listen to or view testimonials about others’ experiences with epilepsy. Users can set small, achievable goals to improve the way they manage their epilepsy and return later to see their progress. WebEase also includes MyLog, an online health diary for tracking seizures and seizure triggers, medications, stress, and sleep.


The WebEase research team created this tool after conducting a literature search, a computer use survey, a focus group, and a review by content experts and consumers.1 Participants in one study viewed WebEase as interesting, informative, relevant, and easy to use. Users improved in epilepsy self-management, sticking to medication recommendations, sleep quality, sense of ability to effectively manage epilepsy, and support from friends or family following the program.2,3


Download the printable PDF version [PDF – 650 KB] of the web page

  1. DiIorio C, Escoffery C, Yeager KA, et al. WebEase: development of a web-based epilepsy self-management intervention. Prev Chron Dis. 2009;6(1):A28.
  2. DiIorio C, Escoffery C, McCarty F, et al. Evaluation of WebEase: an epilepsy self-management website. Health Educ Res. 2009;24(2):185–197.
  3. DiIorio C, Bamps Y, Reisinger-Walker E, Escoffery C. Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy Behav. 2011;22(3):469–474.